Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Electra Therapeutics Promotes Chris Clark To Chief Financial Officer

PUBLIC · ETRASep 09, 2026•about 3 hours ago

Position

Chief Financial Officer

Company

Electra Therapeutics

Chris Clark
San FranciscoManufacturingBiotechnologyHealth CareScience And Engineering

Description

Electra Therapeutics has announced the promotion of Chris Clark, CFA, to Chief Financial Officer. Mr. Clark joined the company in December 2025 and has over two decades of life sciences investment experience.

Company Information

Company

Electra Therapeutics

Location

San Francisco, California, United States

About

Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.

Don't miss Electra Therapeutics's next move

Get an email the moment Electra Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Kathy
Likely contact at this company
••••••••@••••••••

See Kathy's verified email →

Kellyn
Likely contact at this company
••••••••@••••••••

See Kellyn's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Electra Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Electra Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.